Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50–80 years of age

References

• Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333 - 40; http://dx.doi.org/10.1001/jama.292.11.1333; PMID: 15367555
   PubMed Web of Science ®Google Scholar
• Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng PY, Steiner C, Abedi GR, Anderson LJ, Brammer L, Shay DK. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012; 54:1427 - 36; http://dx.doi.org/10.1093/cid/cis211; PMID: 22495079
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057 - 62; PMID: 20798667
   PubMedGoogle Scholar
• Topham DJ, Tripp RA, Doherty PC. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997; 159:5197 - 200; PMID: 9548456
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159 - 69; http://dx.doi.org/10.1016/j.vaccine.2005.08.105; PMID: 16213065
   PubMed Web of Science ®Google Scholar
• Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993; 167:584 - 92; http://dx.doi.org/10.1093/infdis/167.3.584; PMID: 8440930
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013. MMWR Morb Mortal Wkly Rep 2013; 62:119 - 23; PMID: 23425960
   PubMed Web of Science ®Google Scholar
• Webster RG. Immunity to influenza in the elderly. Vaccine 2000; 18:1686 - 9; http://dx.doi.org/10.1016/S0264-410X(99)00507-1; PMID: 10689149
   PubMed Web of Science ®Google Scholar
• Lessler J, Riley S, Read JM, Wang S, Zhu H, Smith GJ, Guan Y, Jiang CQ, Cummings DA. Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS Pathog 2012; 8:e1002802; http://dx.doi.org/10.1371/journal.ppat.1002802; PMID: 22829765
   PubMed Web of Science ®Google Scholar
• Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, Kemble GW, Arvin AM, Greenberg HB. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 2007; 81:215 - 28; http://dx.doi.org/10.1128/JVI.01957-06; PMID: 17050593
   PubMed Web of Science ®Google Scholar
• Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667 - 71; http://dx.doi.org/10.1038/nature06890; PMID: 18449194
   PubMed Web of Science ®Google Scholar
• Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, Zheng NY, Lee JH, Huang M, Qu X, Edupuganti S, et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A 2012; 109:9047 - 52; http://dx.doi.org/10.1073/pnas.1118979109; PMID: 22615367
   PubMed Web of Science ®Google Scholar
• Ellebedy AH, Ahmed R. Re-engaging cross-reactive memory B cells: the influenza puzzle. Front Immunol 2012; 3:53; http://dx.doi.org/10.3389/fimmu.2012.00053; PMID: 22566934
   PubMed Web of Science ®Google Scholar
• O’Donnell CD, Wright A, Vogel LN, Wei CJ, Nabel GJ, Subbarao K. Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus. J Virol 2012; 86:8625 - 33; http://dx.doi.org/10.1128/JVI.00147-12; PMID: 22674976
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, Cho GJ, Hwang TG, Kim WJ. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. Vaccine 2010; 28:3929 - 35; http://dx.doi.org/10.1016/j.vaccine.2010.03.067; PMID: 20394719
   PubMed Web of Science ®Google Scholar
• Bucasas KL, Franco LM, Shaw CA, Bray MS, Wells JM, Niño D, Arden N, Quarles JM, Couch RB, Belmont JW. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis 2011; 203:921 - 9; http://dx.doi.org/10.1093/infdis/jiq156; PMID: 21357945
   PubMed Web of Science ®Google Scholar
• Franco LM, Bucasas KL, Wells JM, Niño D, Wang X, Zapata GE, Arden N, Renwick A, Yu P, Quarles JM, et al. Integrative genomic analysis of the human immune response to influenza vaccination. eLife 2013; 2:e00299; http://dx.doi.org/10.7554/eLife.00299; PMID: 23878721
   PubMed Web of Science ®Google Scholar
• Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009; 459:931 - 9; http://dx.doi.org/10.1038/nature08157; PMID: 19525932
   PubMed Web of Science ®Google Scholar
• Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197 - 201; http://dx.doi.org/10.1126/science.1176225; PMID: 19465683
   PubMed Web of Science ®Google Scholar
• Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945 - 52; http://dx.doi.org/10.1056/NEJMoa0906453; PMID: 19745214
   PubMed Web of Science ®Google Scholar
• Beyer WE, Palache AM, Sprenger MJ, Hendriksen E, Tukker JJ, Darioli R, van der Water GL, Masurel N, Osterhaus AD. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996; 14:1331 - 9; http://dx.doi.org/10.1016/S0264-410X(96)00058-8; PMID: 9004442
   PubMed Web of Science ®Google Scholar
• Seidman JC, Richard SA, Viboud C, Miller MA. Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respir Viruses 2012; 6:52 - 62; http://dx.doi.org/10.1111/j.1750-2659.2011.00268.x; PMID: 21668661
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1128 - 32; PMID: 21866086
   PubMedGoogle Scholar
• Gillim-Ross L, Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 2006; 19:614 - 36; http://dx.doi.org/10.1128/CMR.00005-06; PMID: 17041137
   PubMed Web of Science ®Google Scholar
• Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005; 366:1175 - 81; http://dx.doi.org/10.1016/S0140-6736(05)67338-2; PMID: 16198766
   PubMed Web of Science ®Google Scholar
• Bright RA, Ross TM, Subbarao K, Robinson HL, Katz JM. Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology 2003; 308:270 - 8; http://dx.doi.org/10.1016/S0042-6822(03)00008-4; PMID: 12706077
   PubMed Web of Science ®Google Scholar
• Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006; 295:891 - 4; http://dx.doi.org/10.1001/jama.295.8.joc60020; PMID: 16456087
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Green TD, Bright RA, Ross TM. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 2003; 21:902 - 14; http://dx.doi.org/10.1016/S0264-410X(02)00539-X; PMID: 12547601
   PubMed Web of Science ®Google Scholar
• Ross TM, Xu Y, Bright RA, Robinson HL. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol 2000; 1:127 - 31; http://dx.doi.org/10.1038/77802; PMID: 11248804
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. Guidance for Industry: Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines. Silver Spring, MD, 2007.
   Google Scholar
• Cochran WG. Some Methods for Strengthening the Common χ2 Tests. Biometrics 1954; 10:417 - 51; http://dx.doi.org/10.2307/3001616
   Web of Science ®Google Scholar
• Armitage P. Tests for Linear Trends in Proportions and Frequencies. Biometrics 1955; 11:375 - 86; http://dx.doi.org/10.2307/3001775
   Web of Science ®Google Scholar
• Liu H. Cochran-Armitage Trend Test for Using SAS. SAS Institute Inc, 2004.
   Google Scholar